ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+29.59%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$362M
AUM Growth
+$362M
(+39%)
Cap. Flow
+$67.7M
Cap. Flow
% of AUM
18.69%
Top 10 Holdings %
Top 10 Hldgs %
73.62%
Holding
44
New
10
Increased
13
Reduced
5
Closed
12
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$21.4M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$20.7M |
| 3 |
Vanda Pharmaceuticals
VNDA
|
$18.3M |
| 4 |
Celldex Therapeutics
CLDX
|
$8.89M |
| 5 |
Veracyte
VCYT
|
$8.45M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$17.2M |
| 2 |
Emergent Biosolutions
EBS
|
$9.51M |
| 3 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
$7.59M |
| 4 |
STML
Stemline Therapeutics, Inc.
STML
|
$6.87M |
| 5 |
uniQure
QURE
|
$5.51M |
Sector Composition
| 1 | Healthcare | 86.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $65M | 17.89% | 4,590,199 +378,800 | +9% | +$5.36M |
|
|
SRNE
2
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $38.5M | 10.61% | 2,186,520 -27,523 | -1% | -$485K |
|
|
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $31.5M | 8.67% | 1,000,000 +679,133 | +212% | +$21.4M |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $26.8M | 7.38% | 2,923,065 +773,158 | +36% | +$7.09M |
|
|
CASC
5
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $21M | 5.79% | 5,617,003 +1,125,367 | +25% | +$4.21M |
|
|
6
Acadia Pharmaceuticals
ACAD
$4.38B
| $20.7M | 5.71% | +495,000 | New | +$20.7M |
|
|
AGEN
7
Agenus
AGEN
$133M
| $19M | 5.23% | 2,199,137 +151,166 | +7% | +$1.3M |
|
|
8
Vanda Pharmaceuticals
VNDA
$279M
| $18.3M | 5.03% | +1,438,693 | New | +$18.3M |
|
|
LJPC
9
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $15M | 4.13% | 611,999 +150,500 | +33% | +$3.69M |
|
|
TLGT
10
DELISTED
Teligent, Inc
TLGT
| $11M | 3.04% | 1,753,682 +1,032,774 | +143% | +$6.51M |
|
|
11
Celldex Therapeutics
CLDX
$1.47B
| $8.89M | 2.45% | +352,350 | New | +$8.89M |
|
|
12
Veracyte
VCYT
$2.39B
| $8.45M | 2.33% | +758,497 | New | +$8.45M |
|
|
PTX
13
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $7.4M | 2.04% | 1,250,167 -145,000 | -10% | -$858K |
|
|
INNL
14
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $7.28M | 2% | 497,422 +272,422 | +121% | +$3.99M |
|
|
SIOX
15
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $6.93M | 1.91% | +340,000 | New | +$6.93M |
|
16
Tonix Pharmaceuticals
TNXP
$260M
| $6.78M | 1.87% | 755,300 | – | – |
|
|
NDRM
17
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $5.7M | 1.57% | +371,111 | New | +$5.7M |
|
|
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.43B
| $5.67M | 1.56% | 267,747 +52,042 | +24% | +$1.1M |
|
|
BLCM
19
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $5.58M | 1.54% | 262,515 -212,500 | -45% | -$4.52M |
|
|
RCPT
20
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $5.04M | 1.39% | 26,500 -17,500 | -40% | -$3.33M |
|
21
Heron Therapeutics
HRTX
$207M
| $4.67M | 1.29% | +150,000 | New | +$4.67M |
|
|
ADYX
22
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $4.22M | 1.16% | +800,000 | New | +$4.22M |
|
23
Vericel Corp
VCEL
$1.83B
| $3.87M | 1.07% | 1,083,486 +24,666 | +2% | +$88.1K |
|
|
ADAP
24
Adaptimmune Therapeutics
ADAP
$15.6M
| $3.37M | 0.93% | +183,900 | New | +$3.37M |
|
25
Fortress Biotech
FBIO
$76.8M
| $3.12M | 0.86% | 929,531 +329,531 | +55% | +$1.11M |
|